Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › MANKIND

MANKIND

Mankind Pharma Limited
Mid-capPharma ↗

What the six lenses say about MANKIND — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹2532.0
2026-07-10
VWAP · 1Y anchor
₹2350
+7.7% from VWAP
P/E · TTM
54.6×
TTM EPS ₹46.3
52-week range
79%
position low→high
RSI(14)
59
momentum

Own sector index

Pharma ↗
Overweight

1M

+6.2%

3M

+15.8%

1Y

+16.2%

Breadth >EMA21

72%

How MANKIND’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
7.5
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Mid-cap cohortDRaw
TechnicalD1095›

The actual numbers

Price vs VWAP (1y)+7.7%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+9.2%
Price vs 50-EMA+5.1%
RSI(14)59
RS vs Nifty 500 · 3M+18.5%
RS vs sector · 3M+6.0%
52-week range79%
Volume vs 30d avg1.04×
Volume vs 60d avg0.87×
ATR(14) · volatility69.4
Bollinger width · vol contraction0.102
FundamentalD866›

The actual numbers

Return on equity (ROE)13.1%
Return on capital (ROCE)13.5%
Operating margin20.8%
Net margin13.6%
Revenue growth · YoY+16.3%
EPS growth · YoY-6.1%
Debt / equity0.39×

Full 8-quarter history in the financials table below.

ValuationD26›

The actual numbers

P/E (TTM)54.6×
TTM EPS₹46.3
52-week range79%
CatalystD957›

The actual numbers

Earnings & momentum58
Capital actions35
Governance98

Every filing in the corporate-announcements panel below.

FlowD550›

The actual numbers

Promoter holding72.7%
Delivery · 30d avg51.5%
Up/down-day asymmetry-2.1pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D10 + D5 ) ÷ 2 = 7.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
91
Conviction score 91/100 · avg-decile strength 7.5/10
Conviction score91/100›
TechnicalD10›
FundamentalD8›
ValuationD2›
CatalystD9›
FlowD5›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+1.3pp
+2.7pp
+3.3pp
+22.2pp
+21.7pp
+5.0pp
Nifty 500
Broad-market baseline
+0.9pp
+2.6pp
+2.7pp
+18.5pp
+16.7pp
+1.2pp
Sector
Own-sector index
—
—
+0.4pp
+6.0pp
+2.3pp
-16.7pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

MANKIND daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
2532.00+40.80

Relative strength

RS vs baseline · rebased to 100

MANKIND ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
117.23+1.02

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)2,8933,0773,2303,0793,5703,6973,5673,443
↳ change QoQ—+6.3%+5.0%-4.7%+15.9%+3.6%-3.5%-3.5%
EBITDA (₹cr)782959907683847921919930
EBITDA margin27.0%31.2%28.1%22.2%23.7%24.9%25.8%27.0%
PAT (₹cr)543659385425445520414559
↳ change QoQ—+21.3%-41.6%+10.5%+4.7%+16.9%-20.4%+35.0%
Net margin18.8%21.4%11.9%13.8%12.5%14.1%11.6%16.2%
EPS (₹)13.3916.319.4510.2010.6212.399.9013.43
D/E————————
YoY growth · Mar '26Revenue +11.8% YoYPAT +31.5% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 15 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Jun '26
    MEDIUMgovernance
    Cessation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Jun '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Jun '26
    LOWgovernance
    Allotment of Securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Jun '26
    HIGHcapital
    Acquisition
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 27 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 19 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 19 May '26
    MEDIUMgovernance
    Resignation of Director/KMP/SMP
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 May '26
    LOWgovernance
    ESOP/ESOS/ESPS
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 May '26
    MEDIUMgovernance
    Cessation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds MANKIND

Mutual funds holding MANKIND (10)

FundWeightAUM ₹crGrade
SBI Large Cap Reg Gr1.88%55,064
Nippon India Large Cap Instl Bns0.84%53,227
Nippon India Large Cap Gr0.84%53,227
Nippon India Large Cap Dir Bns0.84%53,227
Nippon India Large Cap Bns0.84%53,227
Nippon India Growth Md Cp Reg Gr Bns1.76%49,169
Nippon India Growth Mid Cap Dir Bns1.76%49,169
Nippon India Growth Md Cp Reg Gr PlGrOpt1.76%49,169
HDFC Large Cap Gr1.72%37,808
Axis ELSS Tax Saver Fd Gr1.07%31,023

ETFs holding MANKIND (10)

ETFWeightGrade
Nippon India Nifty Pharma ETF3.11%
ICICI Pru Nifty Healthcare ETF2.65%
DSP Nifty Healthcare ETF2.59%
Aditya BSL Nifty Healthcare ETF2.59%
Axis NIFTY Healthcare ETF2.59%
Motilal Oswal BSE Select IPO ETF2.49%
Mirae Asset Nifty 500 Healthcare ETF2.13%
Motilal Oswal BSE Healthcare ETF1.80%
Kotak Nifty Midcap 50 ETF1.28%
LIC MF Nifty Midcap 100 ETF0.81%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma